Integrated bioinformatics analysis and biological experiments to identify key immune genes in vascular dementia

This study aimed to identify key immune genes to provide new perspectives on the mechanisms and diagnosis of vascular dementia (VaD) based on bioinformatic methods combined with biological experiments in mice.

We obtained gene expression profiles from a Gene Expression Omnibus database (GSE186798). The gene expression data were analysed using integrated bioinformatics and machine learning techniques to pinpoint potential key immune-related genes for diagnosing VaD. Moreover, the diagnostic accuracy was evaluated through receiver operating characteristic curve analysis. The microRNA, transcription factor (TF), and drug-regulating hub genes were predicted using the database. Immune cell infiltration has been studied to investigate the dysregulation of immune cells in patients with VaD. To evaluate cognitive impairment, mice with bilateral common carotid artery stenosis (BCAS) were subjected to behavioural tests 30 d after chronic cerebral hypoperfusion. The expression of hub genes in the BCAS mice was determined using a quantitative polymerase chain reaction(qPCR).

The results of gene set enrichment and gene set variation analyses indicated that immune-related pathways were upregulated in patients with VaD. A total of 1620 immune genes were included in the combined immune dataset, and 323 differentially expressed genes were examined using the GSE186798 dataset. Thirteen potential genes were identified using differential gene analysis. Protein-protein interaction network design and functional enrichment analysis were performed using the immune system as the main subject. To evaluate the diagnostic value, two potential core genes were selected using machine learning. Two putative hub genes, Rac family small GTPase 1(RAC1) and CKLF-like MARVEL transmembrane domain containing 5 (CMTM5) exhibit good diagnostic value. Their high confidence levels were confirmed by validating each biomarker using a different dataset. According to GeneMANIA, VaD pathophysiology is strongly associated with immune and inflammatory responses. The data were used to construct miRNA hub gene, TFs-hub gene, and drug-hub gene networks. Varying levels of immune cell dysregulation were also observed. In the animal experiments, a BCAS mouse model was employed to mimic VaD in humans, further confirmed using the Morris water maze test. The mRNA expression of RAC1 and CMTM5 was significantly reduced in the BCAS group, which was consistent with the results of the integrated bioinformatics analysis.

RAC1 and CMTM5 are differentially expressed in the frontal lobes of BCAS mice, suggesting their potential as biomarkers for diagnosing and prognosis of VaD. These findings pave the way for exploring novel molecular mechanisms aimed at preventing or treating VaD.